{"id":1488,"date":"2017-01-25T14:50:31","date_gmt":"2017-01-25T13:50:31","guid":{"rendered":"http:\/\/www.alpha1-deutschland.org\/?page_id=1488"},"modified":"2026-08-17T19:01:44","modified_gmt":"2026-08-17T17:01:44","slug":"forschung-studien","status":"publish","type":"page","link":"https:\/\/alpha1-deutschland.org\/en\/forschung-studien","title":{"rendered":"Research & Studies"},"content":{"rendered":"
<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n
\n\t
\n

Research and studies<\/span><\/h1>\n<\/div>\n
\n

An overview of all ongoing clinical trials in the EU is now available on a website of the European Medicines Agency (EMA), in all European languages. The German page can be accessed at [link to German page]. https:\/\/euclinicaltrials.eu\/search-for-clinical-trials\/?lang=de<\/a>. In the search field that appears, you must enter the disease of interest (e.g., alpha-1 antitrypsin) and start the search. All ongoing studies will then be displayed (unfortunately, these are not yet translated into German). By clicking on the relevant studies, you will be taken to pages containing all the relevant information. If you are interested in participating, you should first check whether patients are being recruited in Germany at all, and then whether you meet all the inclusion criteria and none of the exclusion criteria. If all these criteria apply, you can express your interest in participating by email to a study center. Independent of this EMA website, Alpha1 Germany will continue to provide information about the most important studies here in the form of short articles.<\/p>\n

A more elegant way to access the list of studies than the keyword search described above is offered by the tool provided by the EMA. interactive map of Europe<\/u><\/b>.<\/a><\/p>\n

An even simpler (because it is already organized by disease) and also partially German-language access to clinical trials is offered https:\/\/klinischestudien.de<\/a>. Please note that the link to register for a clinical trial leads to the operator of the website, not to the study center of the study in question!<\/p>\n

Here you will find many more calls for studies:<\/p>\n

To the search mask of National Library of Medicine<\/a>.<\/p>\n

Current studies of Thorax Clinic Heidelberg<\/a> for COPD.<\/p>\n

A notice:<\/h3>\n

Many of the scientific texts and links are in English. Therefore, we can offer you the following translation aid:\u00a0Free translator from DEEPL<\/a>\u00a0I highly recommend it.<\/p>\n

Below you will find the latest articles from the 'Research and Studies' section. The reports and calls for participation in clinical trials are for informational purposes only and do not constitute a recommendation to participate.<\/p>\n

Reports and calls for participation in clinical trials are for informational purposes only and do not constitute a recommendation to participate. If you have any questions about participating, always consult your doctor or another qualified healthcare professional before making your personal decision.<\/p>\n

 <\/p>\n<\/div>\n<\/div>\n\n\n\n\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n\n\t

\n\t\t
\n\t\t\t
\n\t\t\t\t\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t
<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
Research and studies<\/a><\/div><\/div>
\"Vier<\/div><\/div><\/div>
<\/div>
New research on Alpha-1: Congratulations to Dr. Andreas Hoheisel for the 2025 research award!<\/span><\/a>

New research on Alpha-1: Congratulations to Dr. Andreas Hoheisel for the 2025 research award!<\/span><\/h3>November 18, 2025<\/span><\/span><\/div><\/div><\/div><\/div>
\"A<\/div><\/div><\/div>
<\/div>
DNA and RNA interventions for the treatment of alpha-1 antitrypsin deficiency<\/span><\/a>

DNA and RNA interventions for the treatment of alpha-1 antitrypsin deficiency<\/span><\/h3>November 18, 2025<\/span><\/span><\/div><\/div><\/div><\/div>
\"CALM-QE<\/div><\/div><\/div>
<\/div>
CALM\u2011QE \u2013 Artificial intelligence for a better understanding of asthma and COPD<\/span><\/a>

CALM\u2011QE \u2013 Artificial intelligence for a better understanding of asthma and COPD<\/span><\/h3>September 22, 2025<\/span><\/span><\/div><\/div><\/div><\/div>
\"\"<\/div><\/div><\/div>
<\/div>
PerMed-COPD \u2013 Patients at the Center of Research<\/span><\/a>

PerMed-COPD \u2013 Patients at the Center of Research<\/span><\/h3>September 22, 2025<\/span><\/span><\/div><\/div><\/div><\/div>
\"Mit<\/div><\/div><\/div>
<\/div>
ALPHA \u2013 The new patient questionnaire for assessing quality of life in alpha-1 antitrypsin deficiency<\/span><\/a>

ALPHA \u2013 The new patient questionnaire for assessing quality of life in alpha-1 antitrypsin deficiency<\/span><\/h3>September 22, 2025<\/span><\/span><\/div><\/div><\/div><\/div><\/div><\/div>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t
<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n\t
\n\t\t
\n\t\t\t